HNGE Hinge Health, Inc.

NYSE www.hingehealth.com


$ 47.97 $ 3.10 (6.16 %)    

Tuesday, 04-Nov-2025 18:31:41 EST
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 53.44
$ 49.00
$ 46.69 x 1
$ 50.25 x 300
$ 48.00 - $ 53.80
$ 33.42 - $ 62.18
3,699,408
na
2.35B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Hinge Health (NYSE:HNGE) raises FY2025 sales outlook from $548.000 million-$552.000 million to $572.000 million-$574.000 millio...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q4 sales of $155.000 million-$157.000 million vs $145.468 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by...

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

Core News & Articles

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $47 to $59.

Core News & Articles

B of A Securities analyst Brad Sills maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $42 to $64.

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly earnings of $0.68 per share which beat the analyst consensus estimate of $0.09 by 6...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION